CD8A and neoplasm: The secretion of these factors inhibits the activation of DCs, CD8+ cytotoxic T lymphocytes, and NK cells, thereby facilitating tumor cells’ evasion of immune surveillance and contributing to tumor development, invasion, and metastasis [4].